Infosys and University of Cambridge launch AI lab in London to supercharge innovation
Infosys has taken a major step forward in the UK tech landscape with the launch of its expanded Living Labs in London and a newly ... Read More
Olatec Therapeutics set to launch dapansutrile Phase 2 trial in Parkinson’s disease
Olatec Therapeutics, Inc. (Olatec), a leader in the field of selective NLRP3 inhibitors, has embarked on a journey to tackle Parkinson's disease, a neurodegenerative disorder ... Read More
NeoGenomics wraps up takeover of liquid biopsy platform company Inivata
NeoGenomics, a US-based cancer diagnostics and pharma services company, has wrapped up its previously announced $390 million takeover of Inivata, a liquid biopsy platform company ... Read More